Article Details

EMA starts evaluating the use of Kineret in adult COVID-19 patients at increased risk of severe ...

Retrieved on: 2021-07-19 09:10:55

Tags for this article:

Click the tags to see associated articles and topics

EMA starts evaluating the use of Kineret in adult COVID-19 patients at increased risk of severe .... View article details on hiswai:

Excerpt

It is thought that this could also help reduce the inflammation and tissue damage associated with COVID-19. EMA's human medicines committee (CHMP) ...

Article found on: www.ema.europa.eu

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up